Coming off a GLP-1 — how to keep what you worked for

The question arrives around month five, almost always in the same tone: so what happens when I stop. Sometimes it is cost. Sometimes the goal weight has been hit. Sometimes it is simply the reasonable instinct that a weekly injection was never meant to be permanent. Whatever the reason, this is the part of the story the before-and-after posts skip entirely — and it is the part that decides whether any of it mattered.

I wrote the week-by-week version of what happens going up in The GLP-1 results timeline — what actually changes, week by week. This is the other half: what happens on the way down, and how to come off without watching the whole thing reverse.

What actually changes when you stop

Semaglutide and tirzepatide work by mimicking gut hormones that suppress appetite and slow gastric emptying. When the drug clears, that signal clears with it. Appetite comes back — not as a failure of willpower, but as pharmacology running in reverse. Patients describe it as the food noise switching back on, sometimes louder than they remembered. Expecting that is most of the battle; being blindsided by it is how people conclude they have failed and give up in the first month.

The published follow-up data is blunt about the consequence: on average, people who stop these medications without a structured plan regain a large share of what they lost within a year, and the cardiometabolic gains drift back toward baseline with it. That is the average, not a verdict on you — but it is the reason we treat the exit as a real clinical event rather than the absence of one.

The three things that decide whether it holds

• How much muscle you kept. Rapid weight loss costs lean mass unless you actively defend it, and lean mass is most of your resting metabolism. Someone who lost forty pounds with a meaningful chunk of it muscle comes off the medication with a slower engine than they started with — a genuinely worse position than before. Protein at every meal and resistance training two to three times a week is the whole defense, and it has to start on day one of treatment, not at the taper.
• Whether the metabolic drivers were addressed. If insulin resistance, a thyroid running at the bottom of the range, a flattened cortisol curve, poor sleep, or untreated apnea were part of why the weight went on originally, the medication was overriding them, not fixing them. Remove the override and the original physiology is still sitting there. This is where the lab work earns its keep.
• What replaced the medication’s job. The drug did something specific: it made a smaller amount of food feel like enough. Something has to do that work afterward — meal structure with real protein and fiber, eating on a schedule rather than reactively, and enough sleep that ghrelin and leptin are not sabotaging you by Wednesday. None of it is exotic. All of it has to be in place before the last dose.

How we actually taper

Stopping abruptly from a full dose is the version that fails most predictably. The approach we use is slower and gives the appetite signal time to return in increments the new habits can absorb:

• Start the exit three months out. Protein target, resistance training, and sleep are non-negotiable and in place well before the dose moves. If they are not established, we do not start the taper.
• Step down, do not jump off. We reduce to the next dose down and hold for four to six weeks, watching appetite, weight, and how the eating pattern holds. Steady is the goal; the scale is allowed to be flat.
• Consider a maintenance dose instead of zero. For a lot of patients the right answer is not off — it is the lowest dose that holds the result. Obesity behaves like a chronic condition, and nobody expects a blood pressure medication to be a three-month course. There is no prize for stopping.
• Re-check the labs at the bottom. Fasting glucose, A1c, lipids, thyroid, and ferritin, plus body composition if we have a baseline. This is what tells us whether the metabolic win actually held, which is the win that mattered.
• Keep a defined check-in. A regain of a few pounds caught at month two is a small adjustment. Caught at month ten it is starting over.

The signs you are not ready to stop yet

We push the taper back when someone is still under-eating protein, has not built any resistance training habit, is sleeping badly or has untreated apnea, is in an acutely stressful stretch of life, or is still actively losing and has not held a stable weight for a couple of months. None of these are character judgments — they are just conditions under which the exit reliably fails, and there is no reason to spend the result to prove it.

The medication buys you a window of quiet. What you build in that window is the only thing that stays when it closes.

If you are on a GLP-1 and thinking about the end of it — or you came off already and watched the weight start climbing back — that is a plan worth making deliberately rather than discovering by accident. Bring your current dose, your recent labs, and an honest picture of what you eat and how you train, and we will map the exit with you.

Semaglutide and tirzepatide are prescription medications that require medical evaluation and ongoing supervision. Do not change or stop a prescribed dose without speaking to the clinician managing it. The patterns above are general clinical observations, not guarantees, and this article is not medical advice.

The journal is written by Dr. Nazzar from the practice. Articles reflect clinical observation and current research, not personalized medical advice. To explore your own case, schedule a consultation.